| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TUBA1B ATXN3L RSPH1 TUBA1A GCC2 TUBA1C PKD2 ATXN3 RSPH6A CHMP2A TUBA4A STAG2 | 5.78e-06 | 720 | 71 | 12 | GO:0000226 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | TUBA1B CACUL1 WDHD1 TUBA1A ANAPC1 POLA1 TUBA1C PKD2 PLCB1 SNX33 CHMP2A TUBA4A STAG2 RAD21 | 7.69e-06 | 1014 | 71 | 14 | GO:0000278 |
| GeneOntologyBiologicalProcess | protein localization to cytosolic proteasome complex | 1.17e-05 | 2 | 71 | 2 | GO:1904327 | |
| GeneOntologyBiologicalProcess | microtubule-based process | TUBA1B ATXN3L RSPH1 TUBA1A GCC2 TUBA1C PKD2 ATXN3 APOB RSPH6A CHMP2A TUBA4A STAG2 | 5.73e-05 | 1058 | 71 | 13 | GO:0007017 |
| GeneOntologyBiologicalProcess | protein quality control for misfolded or incompletely synthesized proteins | 9.60e-05 | 26 | 71 | 3 | GO:0006515 | |
| GeneOntologyCellularComponent | nuclear chromosome | 2.47e-05 | 254 | 71 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | THOC1 RANBP17 KMT2C NCOA6 GTF2E1 SETD1B ANAPC1 POLA1 GON4L YY1AP1 MPHOSPH10 MED1 MBD2 CHMP2A BRMS1 | 4.87e-05 | 1377 | 71 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | radial spoke head | 1.13e-04 | 5 | 71 | 2 | GO:0001535 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.15e-04 | 140 | 71 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | mitotic cohesin complex | 2.36e-04 | 7 | 71 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | nuclear periphery | 2.91e-04 | 171 | 71 | 5 | GO:0034399 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 3.50e-04 | 276 | 71 | 6 | GO:0000775 | |
| GeneOntologyCellularComponent | chromosomal region | 5.61e-04 | 421 | 71 | 7 | GO:0098687 | |
| GeneOntologyCellularComponent | cohesin complex | 6.13e-04 | 11 | 71 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | condensed chromosome | 6.14e-04 | 307 | 71 | 6 | GO:0000793 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 7.34e-04 | 12 | 71 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | radial spoke | 1.16e-03 | 15 | 71 | 2 | GO:0001534 | |
| GeneOntologyCellularComponent | Ino80 complex | 1.50e-03 | 17 | 71 | 2 | GO:0031011 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.08e-03 | 20 | 71 | 2 | GO:0042405 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.13e-03 | 75 | 71 | 3 | GO:0035097 | |
| MousePheno | increased salivary adenocarcinoma incidence | 1.46e-05 | 2 | 54 | 2 | MP:0000621 | |
| Domain | Alpha_tubulin | 2.38e-08 | 9 | 71 | 4 | IPR002452 | |
| Domain | - | 8.87e-07 | 20 | 71 | 4 | 3.30.1330.20 | |
| Domain | - | 1.09e-06 | 21 | 71 | 4 | 1.10.287.600 | |
| Domain | Tubulin_C | 1.33e-06 | 22 | 71 | 4 | SM00865 | |
| Domain | Tubulin_C | 1.33e-06 | 22 | 71 | 4 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.33e-06 | 22 | 71 | 4 | IPR018316 | |
| Domain | - | 1.33e-06 | 22 | 71 | 4 | 3.40.50.1440 | |
| Domain | Tubulin_C | 1.61e-06 | 23 | 71 | 4 | IPR023123 | |
| Domain | TUBULIN | 1.61e-06 | 23 | 71 | 4 | PS00227 | |
| Domain | Tubulin | 1.61e-06 | 23 | 71 | 4 | IPR000217 | |
| Domain | Tub_FtsZ_C | 1.61e-06 | 23 | 71 | 4 | IPR008280 | |
| Domain | Tubulin | 1.61e-06 | 23 | 71 | 4 | SM00864 | |
| Domain | Tubulin_CS | 1.61e-06 | 23 | 71 | 4 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 1.92e-06 | 24 | 71 | 4 | IPR003008 | |
| Domain | Tubulin | 1.92e-06 | 24 | 71 | 4 | PF00091 | |
| Domain | Ataxin-3 | 1.42e-05 | 2 | 71 | 2 | IPR033865 | |
| Domain | UIM | 4.12e-05 | 18 | 71 | 3 | PF02809 | |
| Domain | UIM | 6.67e-05 | 21 | 71 | 3 | SM00726 | |
| Domain | JOSEPHIN | 8.51e-05 | 4 | 71 | 2 | PS50957 | |
| Domain | Josephin | 8.51e-05 | 4 | 71 | 2 | IPR006155 | |
| Domain | Josephin | 8.51e-05 | 4 | 71 | 2 | PF02099 | |
| Domain | Josephin | 8.51e-05 | 4 | 71 | 2 | SM01246 | |
| Domain | UIM | 1.01e-04 | 24 | 71 | 3 | PS50330 | |
| Domain | UIM_dom | 1.14e-04 | 25 | 71 | 3 | IPR003903 | |
| Domain | BEX | 1.41e-04 | 5 | 71 | 2 | IPR007623 | |
| Domain | Di19_Zn_binding_dom | 2.96e-04 | 7 | 71 | 2 | IPR008598 | |
| Domain | zf-Di19 | 2.96e-04 | 7 | 71 | 2 | PF05605 | |
| Domain | TF_A-like/BEX | 1.26e-03 | 14 | 71 | 2 | IPR021156 | |
| Domain | BEX | 1.26e-03 | 14 | 71 | 2 | PF04538 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.45e-03 | 15 | 71 | 2 | IPR001711 | |
| Domain | EF-hand_like | 1.45e-03 | 15 | 71 | 2 | PF09279 | |
| Domain | PIPLC_Y_DOMAIN | 1.45e-03 | 15 | 71 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 1.45e-03 | 15 | 71 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.45e-03 | 15 | 71 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 1.45e-03 | 15 | 71 | 2 | PF00387 | |
| Domain | PLCYc | 1.45e-03 | 15 | 71 | 2 | SM00149 | |
| Domain | Post-SET_dom | 1.65e-03 | 16 | 71 | 2 | IPR003616 | |
| Domain | PostSET | 1.65e-03 | 16 | 71 | 2 | SM00508 | |
| Domain | IBN_N | 1.65e-03 | 16 | 71 | 2 | SM00913 | |
| Domain | POST_SET | 1.65e-03 | 16 | 71 | 2 | PS50868 | |
| Domain | Importin-beta_N | 1.87e-03 | 17 | 71 | 2 | IPR001494 | |
| Domain | PI-PLC-X | 2.10e-03 | 18 | 71 | 2 | PF00388 | |
| Domain | PLCXc | 2.10e-03 | 18 | 71 | 2 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 2.34e-03 | 19 | 71 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 2.34e-03 | 19 | 71 | 2 | IPR000909 | |
| Domain | - | 3.15e-03 | 261 | 71 | 5 | 1.10.238.10 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 5.68e-08 | 27 | 55 | 5 | MM15674 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.40e-07 | 32 | 55 | 5 | M29848 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.75e-07 | 17 | 55 | 4 | M47768 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.75e-07 | 17 | 55 | 4 | MM14731 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 6.09e-07 | 18 | 55 | 4 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.70e-07 | 19 | 55 | 4 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.70e-07 | 19 | 55 | 4 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 9.59e-07 | 20 | 55 | 4 | M47890 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 9.59e-07 | 20 | 55 | 4 | MM1383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 9.59e-07 | 20 | 55 | 4 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.18e-06 | 21 | 55 | 4 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.18e-06 | 21 | 55 | 4 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.44e-06 | 22 | 55 | 4 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.74e-06 | 23 | 55 | 4 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.74e-06 | 23 | 55 | 4 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.74e-06 | 23 | 55 | 4 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 2.08e-06 | 24 | 55 | 4 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.08e-06 | 24 | 55 | 4 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.47e-06 | 25 | 55 | 4 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.47e-06 | 25 | 55 | 4 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 2.91e-06 | 26 | 55 | 4 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.91e-06 | 26 | 55 | 4 | M47672 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 3.18e-06 | 234 | 55 | 8 | MM14898 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 3.39e-06 | 236 | 55 | 8 | M27185 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 3.40e-06 | 27 | 55 | 4 | MM15549 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 3.96e-06 | 28 | 55 | 4 | M47898 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 4.58e-06 | 29 | 55 | 4 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 4.58e-06 | 29 | 55 | 4 | M27948 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 6.49e-06 | 68 | 55 | 5 | MM14921 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 6.88e-06 | 32 | 55 | 4 | M27491 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 6.88e-06 | 32 | 55 | 4 | MM14730 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 7.80e-06 | 33 | 55 | 4 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 7.80e-06 | 33 | 55 | 4 | M47901 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 8.79e-06 | 191 | 55 | 7 | M29614 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 9.41e-06 | 193 | 55 | 7 | MM14890 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 9.59e-06 | 127 | 55 | 6 | M27181 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 9.92e-06 | 35 | 55 | 4 | M47774 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.05e-05 | 129 | 55 | 6 | MM14894 | |
| Pathway | REACTOME_AGGREPHAGY | 1.11e-05 | 36 | 55 | 4 | MM15669 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.12e-05 | 76 | 55 | 5 | M27215 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.24e-05 | 37 | 55 | 4 | MM15102 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.39e-05 | 38 | 55 | 4 | M14981 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 2.29e-05 | 43 | 55 | 4 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 2.29e-05 | 43 | 55 | 4 | M47773 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.51e-05 | 44 | 55 | 4 | MM14606 | |
| Pathway | REACTOME_AGGREPHAGY | 2.51e-05 | 44 | 55 | 4 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.51e-05 | 44 | 55 | 4 | M27934 | |
| Pathway | KEGG_GAP_JUNCTION | 2.56e-05 | 90 | 55 | 5 | M4013 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.74e-05 | 45 | 55 | 4 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 3.00e-05 | 46 | 55 | 4 | M27828 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 3.17e-05 | 94 | 55 | 5 | MM14515 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.55e-05 | 48 | 55 | 4 | MM15353 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.86e-05 | 49 | 55 | 4 | M891 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 3.87e-05 | 98 | 55 | 5 | M776 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.52e-05 | 51 | 55 | 4 | M26972 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 4.89e-05 | 52 | 55 | 4 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 4.89e-05 | 52 | 55 | 4 | MM15211 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 5.27e-05 | 53 | 55 | 4 | M27651 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 5.67e-05 | 54 | 55 | 4 | M27482 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 6.10e-05 | 55 | 55 | 4 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 6.55e-05 | 56 | 55 | 4 | M2333 | |
| Pathway | REACTOME_KINESINS | 7.03e-05 | 57 | 55 | 4 | MM15714 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 7.03e-05 | 57 | 55 | 4 | M27251 | |
| Pathway | REACTOME_KINESINS | 9.18e-05 | 61 | 55 | 4 | M977 | |
| Pathway | REACTOME_CELL_CYCLE | TUBA1B TUBA1A ANAPC1 POLA1 TUBA1C HJURP CHMP2A TUBA4A STAG2 RAD21 | 9.76e-05 | 603 | 55 | 10 | MM14635 |
| Pathway | REACTOME_M_PHASE | 1.18e-04 | 387 | 55 | 8 | MM15364 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.25e-04 | 66 | 55 | 4 | MM17074 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.30e-04 | 202 | 55 | 6 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.37e-04 | 204 | 55 | 6 | M4217 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.40e-04 | 68 | 55 | 4 | MM14968 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 1.46e-04 | 297 | 55 | 7 | M27050 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 1.48e-04 | 130 | 55 | 5 | MM14627 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.66e-04 | 71 | 55 | 4 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.75e-04 | 72 | 55 | 4 | M26954 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.85e-04 | 73 | 55 | 4 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.85e-04 | 73 | 55 | 4 | MM15672 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.90e-04 | 137 | 55 | 5 | MM15182 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.96e-04 | 138 | 55 | 5 | MM15635 | |
| Pathway | REACTOME_M_PHASE | 1.97e-04 | 417 | 55 | 8 | M27662 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.16e-04 | 76 | 55 | 4 | M48037 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.51e-04 | 79 | 55 | 4 | M27743 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 2.89e-04 | 150 | 55 | 5 | M27440 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | 2.91e-04 | 561 | 55 | 9 | M5336 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.98e-04 | 151 | 55 | 5 | M550 | |
| Pathway | REACTOME_CELL_CYCLE | TUBA1B TUBA1A ANAPC1 POLA1 TUBA1C HJURP CHMP2A TUBA4A STAG2 RAD21 | 3.06e-04 | 694 | 55 | 10 | M543 |
| Pathway | REACTOME_AUTOPHAGY | 3.68e-04 | 158 | 55 | 5 | M27935 | |
| Pathway | REACTOME_HCMV_INFECTION | 4.12e-04 | 162 | 55 | 5 | M29804 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 4.13e-04 | 90 | 55 | 4 | M29841 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 4.13e-04 | 90 | 55 | 4 | MM14979 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 4.87e-04 | 94 | 55 | 4 | M2843 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 5.07e-04 | 95 | 55 | 4 | M6729 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_LOADING | 5.29e-04 | 9 | 55 | 2 | M47868 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 5.71e-04 | 98 | 55 | 4 | MM15352 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 5.79e-04 | 42 | 55 | 3 | M48018 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 6.16e-04 | 100 | 55 | 4 | M27650 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 6.16e-04 | 270 | 55 | 6 | M15514 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 6.59e-04 | 10 | 55 | 2 | M27178 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 6.59e-04 | 10 | 55 | 2 | MM14892 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 6.64e-04 | 102 | 55 | 4 | M27648 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 7.40e-04 | 105 | 55 | 4 | MM15206 | |
| Pubmed | 2.52e-10 | 6 | 72 | 4 | 3785200 | ||
| Pubmed | 5.88e-10 | 7 | 72 | 4 | 36681692 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 1.17e-09 | 8 | 72 | 4 | 16148047 | |
| Pubmed | 2.11e-09 | 9 | 72 | 4 | 21167302 | ||
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 8.25e-09 | 12 | 72 | 4 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 1.19e-08 | 13 | 72 | 4 | 10908577 | |
| Pubmed | 1.66e-08 | 14 | 72 | 4 | 12482968 | ||
| Pubmed | 1.66e-08 | 14 | 72 | 4 | 12486001 | ||
| Pubmed | THOC1 USP34 GTF2E1 WDHD1 XPO5 ANAPC1 FAM50A POLA1 DNAJB4 MED1 PHAX MBD2 STAG2 RAD21 | 1.82e-08 | 1014 | 72 | 14 | 32416067 | |
| Pubmed | The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression. | 2.28e-08 | 84 | 72 | 6 | 26299517 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.97e-08 | 332 | 72 | 9 | 32786267 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 18400243 | ||
| Pubmed | 3.94e-08 | 17 | 72 | 4 | 17360745 | ||
| Pubmed | TUBA1B KMT2C CAAP1 SLC9A1 PAXBP1 LONP2 ANAPC1 FBXO28 TUBA1C TM9SF3 GON4L MPHOSPH10 MED1 MBD2 STAG2 RAD21 | 5.39e-08 | 1497 | 72 | 16 | 31527615 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | THOC1 UBR1 NCOA6 CAAP1 PAXBP1 WDHD1 ANAPC1 ZC3H4 YY1AP1 SNX33 MED1 STAG2 | 6.14e-08 | 774 | 72 | 12 | 15302935 |
| Pubmed | 6.39e-08 | 19 | 72 | 4 | 15691386 | ||
| Pubmed | 6.39e-08 | 19 | 72 | 4 | 15698476 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | THOC1 TUBA1B NCOA6 CAAP1 PAXBP1 ZC3H4 TUBA1C BCORL1 MPHOSPH10 MED1 TUBA4A STAG2 RAD21 | 7.29e-08 | 954 | 72 | 13 | 36373674 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | KMT2C NCOA6 SETD1B ANAPC1 FBXO28 TUBA1C BCORL1 HJURP MBD2 BRMS1 | 7.59e-08 | 495 | 72 | 10 | 27705803 |
| Pubmed | 1.20e-07 | 22 | 72 | 4 | 28117675 | ||
| Pubmed | 1.20e-07 | 22 | 72 | 4 | 15103018 | ||
| Pubmed | 1.29e-07 | 282 | 72 | 8 | 23667531 | ||
| Pubmed | 1.67e-07 | 407 | 72 | 9 | 12693553 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 1.69e-07 | 6 | 72 | 3 | 7651436 | |
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 16327313 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 18613978 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 12090300 | ||
| Pubmed | 2.96e-07 | 7 | 72 | 3 | 11146551 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TUBA1B GTF2E1 FAM50A POLA1 BCORL1 MED1 PHAX STAG2 ZEB2 RAD21 | 5.02e-07 | 608 | 72 | 10 | 36089195 |
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 7.08e-07 | 9 | 72 | 3 | 11953448 | |
| Pubmed | 7.08e-07 | 9 | 72 | 3 | 19103752 | ||
| Pubmed | NCOA6 WDHD1 GCC2 TM9SF3 BCORL1 PLCB1 MPHOSPH10 MED1 CBL STAG2 | 7.76e-07 | 638 | 72 | 10 | 31182584 | |
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 1.39e-06 | 11 | 72 | 3 | 20405035 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | THOC1 KMT2C NCOA6 PAXBP1 TUBA1A ANAPC1 FBXO28 BCORL1 MED1 MBD2 STAG2 RAD21 BRMS1 | 2.27e-06 | 1294 | 72 | 13 | 30804502 |
| Pubmed | 2.40e-06 | 13 | 72 | 3 | 14697242 | ||
| Pubmed | Characterization of vertebrate cohesin complexes and their regulation in prophase. | 3.05e-06 | 14 | 72 | 3 | 11076961 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.05e-06 | 202 | 72 | 6 | 33005030 | |
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 4.23e-06 | 2 | 72 | 2 | 3839072 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 21653538 | ||
| Pubmed | The genomic structure and expression of MJD, the Machado-Joseph disease gene. | 4.23e-06 | 2 | 72 | 2 | 11450850 | |
| Pubmed | The Justy mutation identifies Gon4-like as a gene that is essential for B lymphopoiesis. | 4.23e-06 | 2 | 72 | 2 | 20530203 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 14661975 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 11978767 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 21060878 | ||
| Pubmed | Calpain inhibition is sufficient to suppress aggregation of polyglutamine-expanded ataxin-3. | 4.23e-06 | 2 | 72 | 2 | 17488727 | |
| Pubmed | Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination. | 4.23e-06 | 2 | 72 | 2 | 17764659 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 28676741 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 37122622 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 30231063 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23955261 | ||
| Pubmed | Vulnerability of frontal brain neurons for the toxicity of expanded ataxin-3. | 4.23e-06 | 2 | 72 | 2 | 30576445 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 12914917 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 20064935 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17632007 | ||
| Pubmed | Submembraneous microtubule cytoskeleton: interaction of TRPP2 with the cell cytoskeleton. | 4.23e-06 | 2 | 72 | 2 | 18754774 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 30364204 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 22777893 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17626202 | ||
| Pubmed | Newly identified Gon4l/Udu-interacting proteins implicate novel functions. | 4.23e-06 | 2 | 72 | 2 | 32848183 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 22843411 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 36875652 | ||
| Pubmed | PolyQ-expanded ataxin-3 interacts with full-length ataxin-3 in a polyQ length-dependent manner. | 4.23e-06 | 2 | 72 | 2 | 18668148 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 34220448 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24683430 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 8640226 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 25301414 | ||
| Pubmed | Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin. | 4.23e-06 | 2 | 72 | 2 | 19666135 | |
| Pubmed | Expanded ATXN3 frameshifting events are toxic in Drosophila and mammalian neuron models. | 4.23e-06 | 2 | 72 | 2 | 22337953 | |
| Pubmed | Absence of ataxin-3 leads to cytoskeletal disorganization and increased cell death. | 4.23e-06 | 2 | 72 | 2 | 20637808 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 34716557 | ||
| Pubmed | The transcriptional regulator GON4L is required for viability and hematopoiesis in mice. | 4.23e-06 | 2 | 72 | 2 | 33864850 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23626768 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 20079840 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 25320121 | ||
| Pubmed | The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina. | 4.23e-06 | 2 | 72 | 2 | 33176149 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 36010688 | ||
| Pubmed | Study of subcellular localization and proteolysis of ataxin-3. | 4.23e-06 | 2 | 72 | 2 | 18353661 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 22296162 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 25328666 | ||
| Pubmed | Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology. | 4.23e-06 | 2 | 72 | 2 | 23242710 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23349684 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 18502140 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 16939621 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 16828057 | ||
| Pubmed | Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis. | 4.23e-06 | 2 | 72 | 2 | 35042771 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 12054644 | ||
| Pubmed | Neurodegenerative phosphoprotein signaling landscape in models of SCA3. | 4.23e-06 | 2 | 72 | 2 | 33741019 | |
| Pubmed | 4.67e-06 | 16 | 72 | 3 | 23870121 | ||
| Pubmed | 4.67e-06 | 16 | 72 | 3 | 24368734 | ||
| Pubmed | 4.81e-06 | 322 | 72 | 7 | 26514267 | ||
| Pubmed | 5.67e-06 | 17 | 72 | 3 | 21043528 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TUBA1B GTF2E1 PAXBP1 TUBA1A LONP2 FAM50A ZC3H4 POLA1 TUBA1C DNAJB4 TUBA4A STAG2 RAD21 | 6.00e-06 | 1415 | 72 | 13 | 28515276 |
| Pubmed | 6.07e-06 | 472 | 72 | 8 | 38943005 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.99e-06 | 341 | 72 | 7 | 32971831 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 7.05e-06 | 59 | 72 | 4 | 28813667 | |
| Pubmed | 7.50e-06 | 225 | 72 | 6 | 12168954 | ||
| Pubmed | 8.15e-06 | 653 | 72 | 9 | 22586326 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 9.46e-06 | 20 | 72 | 3 | 29785026 | |
| Pubmed | 1.01e-05 | 506 | 72 | 8 | 30890647 | ||
| Pubmed | 1.10e-05 | 21 | 72 | 3 | 36332009 | ||
| Interaction | TCP11L2 interactions | 8.56e-07 | 21 | 72 | 4 | int:TCP11L2 | |
| Interaction | IFITM5 interactions | 1.51e-06 | 7 | 72 | 3 | int:IFITM5 | |
| Interaction | SOX2 interactions | TUBA1B USP34 KMT2C NCOA6 XPO5 TUBA1A ANAPC1 KCMF1 HJURP OASL ATXN3 MED1 PHAX MBD2 TUBA4A STAG2 ZEB2 RAD21 | 1.79e-06 | 1422 | 72 | 18 | int:SOX2 |
| Interaction | LTA interactions | 2.87e-06 | 28 | 72 | 4 | int:LTA | |
| Interaction | USP37 interactions | 3.48e-06 | 115 | 72 | 6 | int:USP37 | |
| Interaction | BAGE2 interactions | 5.11e-06 | 70 | 72 | 5 | int:BAGE2 | |
| Interaction | POLR1G interactions | THOC1 GTF2E1 WDHD1 XPO5 FAM50A BCORL1 MPHOSPH10 STAG2 ZEB2 RAD21 | 9.00e-06 | 489 | 72 | 10 | int:POLR1G |
| Interaction | PIP5K1P1 interactions | 9.40e-06 | 12 | 72 | 3 | int:PIP5K1P1 | |
| Interaction | ASCL2 interactions | 1.22e-05 | 13 | 72 | 3 | int:ASCL2 | |
| Interaction | H3-3A interactions | TUBA1B KMT2C GTF2E1 SETD1B FAM50A POLA1 BCORL1 MED1 PHAX STAG2 ZEB2 RAD21 | 1.26e-05 | 749 | 72 | 12 | int:H3-3A |
| Interaction | CAPSL interactions | 1.93e-05 | 15 | 72 | 3 | int:CAPSL | |
| Interaction | DHDH interactions | 2.38e-05 | 47 | 72 | 4 | int:DHDH | |
| Interaction | RBBP4 interactions | 3.51e-05 | 573 | 72 | 10 | int:RBBP4 | |
| Interaction | LOXL4 interactions | 3.53e-05 | 104 | 72 | 5 | int:LOXL4 | |
| Interaction | NR3C1 interactions | UBR1 NCOA6 WDHD1 GCC2 TUBA1C TM9SF3 BCORL1 PLCB1 MPHOSPH10 MED1 CBL MBD2 STAG2 | 3.62e-05 | 974 | 72 | 13 | int:NR3C1 |
| Interaction | GRM7 interactions | 4.07e-05 | 19 | 72 | 3 | int:GRM7 | |
| Interaction | SMC5 interactions | THOC1 TUBA1B NCOA6 CAAP1 PAXBP1 ZC3H4 TUBA1C BCORL1 MPHOSPH10 MED1 TUBA4A STAG2 RAD21 | 4.75e-05 | 1000 | 72 | 13 | int:SMC5 |
| Interaction | NXPH3 interactions | 5.49e-05 | 58 | 72 | 4 | int:NXPH3 | |
| Interaction | INSL5 interactions | 5.49e-05 | 58 | 72 | 4 | int:INSL5 | |
| Interaction | RGS4 interactions | 6.41e-05 | 22 | 72 | 3 | int:RGS4 | |
| Interaction | PPIA interactions | TUBA1B NCOA6 GTF2E1 FAM50A ZC3H4 POLA1 ATXN3 MPHOSPH10 MED1 PHAX MBD2 ITK | 6.67e-05 | 888 | 72 | 12 | int:PPIA |
| Interaction | B4GALT2 interactions | 6.73e-05 | 119 | 72 | 5 | int:B4GALT2 | |
| Interaction | H3C1 interactions | KMT2C GTF2E1 PIEZO2 SETD1B ANAPC1 FAM50A ZC3H4 POLA1 GCC2 MBD2 STAG2 RAD21 | 7.66e-05 | 901 | 72 | 12 | int:H3C1 |
| Interaction | ZC2HC1A interactions | 8.09e-05 | 64 | 72 | 4 | int:ZC2HC1A | |
| Interaction | TXNDC9 interactions | 8.18e-05 | 124 | 72 | 5 | int:TXNDC9 | |
| Interaction | CDRT15P3 interactions | 8.39e-05 | 24 | 72 | 3 | int:CDRT15P3 | |
| Interaction | LRRC31 interactions | 9.20e-05 | 205 | 72 | 6 | int:LRRC31 | |
| Interaction | TUBB2B interactions | 9.20e-05 | 205 | 72 | 6 | int:TUBB2B | |
| Interaction | BRINP3 interactions | 9.50e-05 | 25 | 72 | 3 | int:BRINP3 | |
| Interaction | CAPS interactions | 9.50e-05 | 25 | 72 | 3 | int:CAPS | |
| Interaction | SNX21 interactions | 9.68e-05 | 67 | 72 | 4 | int:SNX21 | |
| Interaction | H2BC3 interactions | 9.83e-05 | 406 | 72 | 8 | int:H2BC3 | |
| Interaction | TSPYL6 interactions | 1.03e-04 | 68 | 72 | 4 | int:TSPYL6 | |
| Interaction | CDHR4 interactions | 1.03e-04 | 68 | 72 | 4 | int:CDHR4 | |
| Interaction | ZNF575 interactions | 1.20e-04 | 27 | 72 | 3 | int:ZNF575 | |
| Interaction | ZC2HC1B interactions | 1.34e-04 | 28 | 72 | 3 | int:ZC2HC1B | |
| Interaction | TERF2IP interactions | 1.49e-04 | 552 | 72 | 9 | int:TERF2IP | |
| Interaction | CST11 interactions | 1.50e-04 | 75 | 72 | 4 | int:CST11 | |
| Interaction | EFTUD2 interactions | TUBA1B GTF2E1 PAXBP1 XPO5 TUBA1A LONP2 FAM50A ZC3H4 POLA1 TUBA1C ATXN3 DNAJB4 TUBA4A STAG2 RAD21 | 1.54e-04 | 1449 | 72 | 15 | int:EFTUD2 |
| Interaction | VAV1 interactions | 1.65e-04 | 228 | 72 | 6 | int:VAV1 | |
| Interaction | TUBB4B interactions | 1.66e-04 | 560 | 72 | 9 | int:TUBB4B | |
| Interaction | NCOA6 interactions | 1.71e-04 | 145 | 72 | 5 | int:NCOA6 | |
| Interaction | CAPN10 interactions | 2.01e-04 | 32 | 72 | 3 | int:CAPN10 | |
| Interaction | FAF2 interactions | 2.02e-04 | 451 | 72 | 8 | int:FAF2 | |
| Interaction | TUBB3 interactions | 2.08e-04 | 453 | 72 | 8 | int:TUBB3 | |
| Interaction | BACE2 interactions | 2.12e-04 | 82 | 72 | 4 | int:BACE2 | |
| Interaction | NUP50 interactions | 2.14e-04 | 341 | 72 | 7 | int:NUP50 | |
| Interaction | EML1 interactions | 2.21e-04 | 33 | 72 | 3 | int:EML1 | |
| Interaction | SNRNP200 interactions | 2.31e-04 | 460 | 72 | 8 | int:SNRNP200 | |
| Interaction | SUMO2 interactions | 2.48e-04 | 591 | 72 | 9 | int:SUMO2 | |
| Interaction | KPNA1 interactions | 2.55e-04 | 351 | 72 | 7 | int:KPNA1 | |
| Interaction | TUBA4B interactions | 2.64e-04 | 35 | 72 | 3 | int:TUBA4B | |
| Interaction | MEN1 interactions | THOC1 KMT2C NCOA6 PAXBP1 SETD1B WDHD1 ZC3H4 POLA1 YY1AP1 MPHOSPH10 MED1 RAD21 | 2.65e-04 | 1029 | 72 | 12 | int:MEN1 |
| Interaction | KDM6A interactions | 2.86e-04 | 162 | 72 | 5 | int:KDM6A | |
| Interaction | FAM83F interactions | 2.87e-04 | 36 | 72 | 3 | int:FAM83F | |
| Interaction | KLK11 interactions | 2.87e-04 | 36 | 72 | 3 | int:KLK11 | |
| Interaction | PAX6 interactions | 3.29e-04 | 366 | 72 | 7 | int:PAX6 | |
| Interaction | ZAP70 interactions | 3.30e-04 | 92 | 72 | 4 | int:ZAP70 | |
| Interaction | HCFC2 interactions | 3.30e-04 | 92 | 72 | 4 | int:HCFC2 | |
| Interaction | BAG2 interactions | 3.61e-04 | 622 | 72 | 9 | int:BAG2 | |
| Interaction | INSYN2A interactions | 3.64e-04 | 39 | 72 | 3 | int:INSYN2A | |
| Interaction | CD48 interactions | 3.64e-04 | 39 | 72 | 3 | int:CD48 | |
| Interaction | RCOR1 interactions | 3.73e-04 | 494 | 72 | 8 | int:RCOR1 | |
| Interaction | RBBP7 interactions | 4.43e-04 | 507 | 72 | 8 | int:RBBP7 | |
| Interaction | NUP210P1 interactions | 4.54e-04 | 42 | 72 | 3 | int:NUP210P1 | |
| Interaction | MAP2K2 interactions | 4.76e-04 | 278 | 72 | 6 | int:MAP2K2 | |
| Interaction | NPTN interactions | 4.76e-04 | 278 | 72 | 6 | int:NPTN | |
| Interaction | MLLT11 interactions | 4.87e-04 | 43 | 72 | 3 | int:MLLT11 | |
| Interaction | OPRL1 interactions | 4.89e-04 | 102 | 72 | 4 | int:OPRL1 | |
| Interaction | EMILIN1 interactions | 5.07e-04 | 103 | 72 | 4 | int:EMILIN1 | |
| Interaction | CALML5 interactions | 5.25e-04 | 185 | 72 | 5 | int:CALML5 | |
| Interaction | ITGAD interactions | 5.94e-04 | 46 | 72 | 3 | int:ITGAD | |
| Interaction | PRSS50 interactions | 5.94e-04 | 46 | 72 | 3 | int:PRSS50 | |
| Interaction | SSR2 interactions | 5.94e-04 | 46 | 72 | 3 | int:SSR2 | |
| Interaction | CA10 interactions | 5.94e-04 | 46 | 72 | 3 | int:CA10 | |
| Interaction | NLRP1 interactions | 6.33e-04 | 47 | 72 | 3 | int:NLRP1 | |
| Interaction | TRAV20 interactions | 6.74e-04 | 48 | 72 | 3 | int:TRAV20 | |
| Interaction | WNT7A interactions | 6.74e-04 | 48 | 72 | 3 | int:WNT7A | |
| Interaction | TMPRSS5 interactions | 6.74e-04 | 48 | 72 | 3 | int:TMPRSS5 | |
| Interaction | SERPINB11 interactions | 6.78e-04 | 11 | 72 | 2 | int:SERPINB11 | |
| Interaction | CLEC2D interactions | 6.98e-04 | 197 | 72 | 5 | int:CLEC2D | |
| Interaction | HAPSTR1 interactions | THOC1 TUBA1B USP34 SETD1B XPO5 TUBA1A ANAPC1 TUBA1C PLCB1 MBD2 | 6.99e-04 | 829 | 72 | 10 | int:HAPSTR1 |
| Interaction | PARP1 interactions | NCOA6 GTF2E1 WDHD1 RSPH1 FAM50A POLA1 KCMF1 BCORL1 ATXN3 MPHOSPH10 MED1 STAG2 RAD21 | 7.06e-04 | 1316 | 72 | 13 | int:PARP1 |
| Interaction | CTAG1B interactions | 7.19e-04 | 113 | 72 | 4 | int:CTAG1B | |
| Interaction | SMC1A interactions | 7.25e-04 | 418 | 72 | 7 | int:SMC1A | |
| Interaction | CAD interactions | 7.25e-04 | 418 | 72 | 7 | int:CAD | |
| Interaction | USP13 interactions | 7.43e-04 | 114 | 72 | 4 | int:USP13 | |
| Interaction | COMTD1 interactions | 7.47e-04 | 200 | 72 | 5 | int:COMTD1 | |
| Interaction | CCT8 interactions | 7.55e-04 | 550 | 72 | 8 | int:CCT8 | |
| Interaction | LGALS2 interactions | 8.12e-04 | 12 | 72 | 2 | int:LGALS2 | |
| Interaction | CDK2AP1 interactions | 8.45e-04 | 118 | 72 | 4 | int:CDK2AP1 | |
| Interaction | PPM1M interactions | 9.01e-04 | 53 | 72 | 3 | int:PPM1M | |
| Interaction | MYH2 interactions | 9.01e-04 | 53 | 72 | 3 | int:MYH2 | |
| Cytoband | 12q13.12 | 3.00e-05 | 38 | 72 | 3 | 12q13.12 | |
| GeneFamily | Tubulins | 8.68e-07 | 26 | 52 | 4 | 778 | |
| GeneFamily | Ataxins|MJD deubiquinating enzymes | 4.85e-05 | 4 | 52 | 2 | 997 | |
| GeneFamily | Brain expressed X-linked family | 8.07e-05 | 5 | 52 | 2 | 1217 | |
| GeneFamily | Cohesin complex | 2.25e-04 | 8 | 52 | 2 | 1060 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.34e-03 | 19 | 52 | 2 | 832 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.29e-03 | 34 | 52 | 2 | 487 | |
| GeneFamily | Phospholipases | 6.49e-03 | 42 | 52 | 2 | 467 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | STK4 USP34 UBR1 KMT2C TUBA1A LONP2 KCMF1 MED1 CBL MBD2 TUBA4A STAG2 ZEB2 ITK RAD21 | 1.06e-05 | 1492 | 72 | 15 | M40023 |
| Coexpression | HOLLMANN_APOPTOSIS_VIA_CD40_UP | 2.05e-05 | 203 | 72 | 6 | M9695 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | STK4 USP34 NCOA6 GTF2E1 KIAA0930 ZC3H4 POLA1 PKD2 ATXN3 MED1 MBD2 STAG2 ITK RAD21 | 2.23e-05 | 1394 | 72 | 14 | M9585 |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-07 | 187 | 72 | 6 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-07 | 196 | 72 | 6 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-07 | 196 | 72 | 6 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.26e-07 | 198 | 72 | 6 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.82e-06 | 168 | 72 | 5 | 50991eb794742592a0c96cd9a72460ab339e74ff | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.79e-06 | 176 | 72 | 5 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.03e-05 | 178 | 72 | 5 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-05 | 179 | 72 | 5 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 180 | 72 | 5 | ed4966765a6b25456f68185cf0648c4a3a21d7fe | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 1.12e-05 | 181 | 72 | 5 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | Control-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.28e-05 | 186 | 72 | 5 | 7bc939bf4e71bb4c6409b862c1f6c547d775e089 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.28e-05 | 186 | 72 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-05 | 197 | 72 | 5 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-05 | 198 | 72 | 5 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | Transverse-T_cell-Th1|T_cell / Region, Cell class and subclass | 1.77e-05 | 199 | 72 | 5 | 9271d9d36ffe1c169049d4340258f366916adfaf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-05 | 200 | 72 | 5 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-05 | 200 | 72 | 5 | c57faee6a3d4c73a818c5a25f780741a15b82fc8 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-05 | 200 | 72 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-05 | 200 | 72 | 5 | 4f65e320be904fda16bd305a684e83800dd8e606 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.81e-05 | 200 | 72 | 5 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-T_cells|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.81e-05 | 200 | 72 | 5 | fe6900541241c77285dd5271d183a246fc3b3c83 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-T/NK-Other_T-T_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-05 | 200 | 72 | 5 | df4332d3647bdaebb534d923624f05c0e48c49fa | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.81e-05 | 200 | 72 | 5 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-T/NK-Other_T-T_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-05 | 200 | 72 | 5 | cf0a3a1bc4b07769f174604a5d3503702e4522ee | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.74e-05 | 144 | 72 | 4 | 5e948d4cb913ccd8f82262a1b4d20967aadab3ab | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-04 | 151 | 72 | 4 | 7270b8bbfae659e110bd9d513b602120b25de3dd | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-04 | 156 | 72 | 4 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.19e-04 | 156 | 72 | 4 | bb2876bdf2375866d7509eba3c48322326349fa8 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-04 | 158 | 72 | 4 | cf1b77abd05f18526679c0d305b4dd2caef2b306 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|T_cell / Lineage, cell class and subclass | 1.31e-04 | 160 | 72 | 4 | 66fe86d2f37983761141e5bb3de127f0b4bb0951 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 161 | 72 | 4 | f470b662566131dfe69a2fd01186ac8491196396 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 164 | 72 | 4 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.55e-04 | 167 | 72 | 4 | d041b345014e170e9a45f8c6ef8a37ff56f14750 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-04 | 170 | 72 | 4 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 170 | 72 | 4 | a7184dc41f90caa753860ed0f65a18133f84bc5f | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-04 | 171 | 72 | 4 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 1.73e-04 | 172 | 72 | 4 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-04 | 173 | 72 | 4 | 34357f0e22c4b6d84582492c82c1ea733ca8477d | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 174 | 72 | 4 | 66555c610251ea04f968c258e312d720c18e7cde | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.98e-04 | 178 | 72 | 4 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-MEP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.98e-04 | 178 | 72 | 4 | b8c301d65c0f37941e8e9414d55e90edb6ecc195 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-04 | 180 | 72 | 4 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 2.06e-04 | 180 | 72 | 4 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | metastatic_Brain-T/NK_cells-CD8_low_T|metastatic_Brain / Location, Cell class and cell subclass | 2.06e-04 | 180 | 72 | 4 | 57eced5e314681857a853f7e6bb8b429f157e80e | |
| ToppCell | IIH-cycling-|IIH / Condition, Cell_class and T cell subcluster | 2.11e-04 | 181 | 72 | 4 | 7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078 | |
| ToppCell | IIH-cycling|IIH / Condition, Cell_class and T cell subcluster | 2.11e-04 | 181 | 72 | 4 | ec3e782ce93dcfe1a54fb7284e4e39063614b0e2 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 2.15e-04 | 182 | 72 | 4 | 6745d464c3ff289726aa8164e9a43f407f8e4380 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-04 | 182 | 72 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 182 | 72 | 4 | fa16e194f04250149c82e86551270b244cbc8af4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 184 | 72 | 4 | 4b864c74e2cf7e58d6bd151f955c43d72f035d52 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 2.29e-04 | 185 | 72 | 4 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.29e-04 | 185 | 72 | 4 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.34e-04 | 186 | 72 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.34e-04 | 186 | 72 | 4 | 701eea0016d69f0f9d29b613948f91239096e6c7 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.38e-04 | 187 | 72 | 4 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T|tumor_Lung / Location, Cell class and cell subclass | 2.38e-04 | 187 | 72 | 4 | 530839fb53bb285b22919fde6aa16ce1399615ef | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.38e-04 | 187 | 72 | 4 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 2.43e-04 | 188 | 72 | 4 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.43e-04 | 188 | 72 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-04 | 188 | 72 | 4 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.43e-04 | 188 | 72 | 4 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 2.48e-04 | 189 | 72 | 4 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.48e-04 | 189 | 72 | 4 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-04 | 190 | 72 | 4 | c01a8bfb9fbc0e6f37d7e9be25512eda63acabbc | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-04 | 190 | 72 | 4 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.53e-04 | 190 | 72 | 4 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-04 | 190 | 72 | 4 | cd37ccd30c27cf65eda0a9165f35b7672f5acaf6 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-04 | 191 | 72 | 4 | f7a42a9d7493ea25cd8bd297c22e49e4bad7f0a4 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|metastatic_Brain / Location, Cell class and cell subclass | 2.58e-04 | 191 | 72 | 4 | b98367fdb56ccb335d61035e69cd43c61a7fa816 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.58e-04 | 191 | 72 | 4 | 95ae42d145adb478d886a2259baacc713cd6587b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.58e-04 | 191 | 72 | 4 | c5e22df4a8741b8096cdd1618271fd48d6265846 | |
| ToppCell | Control-Lymphoid-ILC_A|Control / Disease state, Lineage and Cell class | 2.58e-04 | 191 | 72 | 4 | 1ca73582dc3d28322b5ee841010067589d848acc | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-04 | 191 | 72 | 4 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 2.58e-04 | 191 | 72 | 4 | db7b8f8826bf19d6eeee14319570a9e6e99ab2cb | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.58e-04 | 191 | 72 | 4 | 82f4a4b0c35638ca4b2c428d0bb946ea95c1001b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-04 | 191 | 72 | 4 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | ASK452-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.64e-04 | 192 | 72 | 4 | 8269b88ff6073a908f547fcc7c5941f2e8289694 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.64e-04 | 192 | 72 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-04 | 192 | 72 | 4 | 494c5eca0f07fc761f26487a2b937c7056bbe594 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-04 | 193 | 72 | 4 | 95f5611dd9583f339b7c9f52bb478af204fb89ad | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.69e-04 | 193 | 72 | 4 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.69e-04 | 193 | 72 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-04 | 193 | 72 | 4 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 193 | 72 | 4 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass | 2.69e-04 | 193 | 72 | 4 | 5ce93860bc60ce6ecfed3a3d985f84e28781eec1 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.69e-04 | 193 | 72 | 4 | a2fb7482e79d6ce5b6b1d9d0c0811d1c58b4d85d | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.69e-04 | 193 | 72 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-04 | 193 | 72 | 4 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-04 | 193 | 72 | 4 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.69e-04 | 193 | 72 | 4 | 1d724ccb745cfc624119dd6003d53b84b17c94b0 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 193 | 72 | 4 | 5a201ee6f132357c9aacfbad3ae56ed9854c25fd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-04 | 193 | 72 | 4 | c7aeb7001d4be0a7c3269d939ec84d8c6d15e0c9 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.74e-04 | 194 | 72 | 4 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | pdx-Tumor_cells-T7|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.74e-04 | 194 | 72 | 4 | ddcc8f91459afcb9d52a4efb64d9fac4e4f38c7f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-04 | 194 | 72 | 4 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 194 | 72 | 4 | 4c40d6b50675eae52c419d69e719a9223df02ae3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 194 | 72 | 4 | 99a90de637e3babec2131cdd9f05ea965d8a8f30 | |
| Drug | Epothilone D | 4.46e-08 | 12 | 72 | 4 | DB01873 | |
| Drug | Epothilone B | 4.46e-08 | 12 | 72 | 4 | DB03010 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1.21e-07 | 4 | 72 | 3 | DB07574 | |
| Drug | Demecolcine | STK4 USP34 SETD1B ZSCAN20 WDHD1 TUBA1A POLA1 TUBA1C KCMF1 TM9SF3 ATXN3 GON4L TUBA4A ZEB2 | 5.41e-07 | 878 | 72 | 14 | ctd:D003703 |
| Drug | imipramine | 7.75e-07 | 235 | 72 | 8 | CID000003696 | |
| Drug | bp U | 2.06e-06 | 29 | 72 | 4 | CID000368697 | |
| Drug | Z)-combretastatin A-4 | 1.90e-05 | 50 | 72 | 4 | CID000072686 | |
| Drug | TK-B | 2.05e-05 | 51 | 72 | 4 | CID000009074 | |
| Drug | combretastatin | 2.05e-05 | 51 | 72 | 4 | CID000100154 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.35e-05 | 181 | 72 | 6 | 6276_UP | |
| Drug | miconidin | 2.95e-05 | 3 | 72 | 2 | CID000169581 | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 3277_DN | |
| Drug | bromocolchicine | 3.87e-05 | 21 | 72 | 3 | CID000161518 | |
| Drug | Ustiloxin A | 3.87e-05 | 21 | 72 | 3 | CID000164454 | |
| Drug | SRI-3072 | 3.87e-05 | 21 | 72 | 3 | CID000493469 | |
| Drug | colchifoline | 3.87e-05 | 21 | 72 | 3 | CID000100132 | |
| Drug | Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 7204_DN | |
| Drug | 3,4,5-trimethoxyacetophenone | 4.47e-05 | 22 | 72 | 3 | CID000014345 | |
| Drug | AC1L1GIQ | 4.47e-05 | 22 | 72 | 3 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 4.47e-05 | 22 | 72 | 3 | CID000098538 | |
| Drug | SureCN13401588 | 4.47e-05 | 22 | 72 | 3 | CID009897422 | |
| Drug | N-methyldemecolcine | 4.47e-05 | 22 | 72 | 3 | CID000023759 | |
| Drug | NSC-339672 | 4.47e-05 | 22 | 72 | 3 | CID000433930 | |
| Drug | IKP104 | 5.13e-05 | 23 | 72 | 3 | CID000130739 | |
| Drug | fluorescein-colchicine | 5.13e-05 | 23 | 72 | 3 | CID003035871 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 5.13e-05 | 23 | 72 | 3 | CID000006858 | |
| Drug | 3-demethylthiocolchicine | 5.13e-05 | 23 | 72 | 3 | CID000084076 | |
| Drug | 2,3,4-TCB | 5.13e-05 | 23 | 72 | 3 | CID000129239 | |
| Drug | AC1L2P05 | 5.13e-05 | 23 | 72 | 3 | CID000125688 | |
| Drug | 2,3,4-tabp | 5.13e-05 | 23 | 72 | 3 | CID000125548 | |
| Drug | NSC-373301 | 5.13e-05 | 23 | 72 | 3 | CID000341375 | |
| Drug | N-acetylcolchinol | 5.13e-05 | 23 | 72 | 3 | CID000097865 | |
| Drug | NSC355636 | 5.13e-05 | 23 | 72 | 3 | CID000100176 | |
| Drug | moscatilin | 5.85e-05 | 24 | 72 | 3 | CID000176096 | |
| Drug | parbendazole | 5.85e-05 | 24 | 72 | 3 | CID000026596 | |
| Drug | NSC-36768 | 5.85e-05 | 24 | 72 | 3 | CID000165441 | |
| Drug | deacetamidocolchicine | 5.85e-05 | 24 | 72 | 3 | CID000014995 | |
| Drug | tropolone methyl ether | 5.85e-05 | 24 | 72 | 3 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 5.85e-05 | 24 | 72 | 3 | CID000330401 | |
| Drug | NABV | 5.85e-05 | 24 | 72 | 3 | CID000175959 | |
| Drug | colchicide | 5.85e-05 | 24 | 72 | 3 | CID000120712 | |
| Drug | AC1L4TG7 | 5.85e-05 | 24 | 72 | 3 | CID000163705 | |
| Drug | L-IQ | 5.89e-05 | 4 | 72 | 2 | CID015942667 | |
| Drug | trifluralin | 6.00e-05 | 131 | 72 | 5 | CID000005569 | |
| Drug | NBD-colcemid | 6.63e-05 | 25 | 72 | 3 | CID000130594 | |
| Drug | mpMap | 6.63e-05 | 25 | 72 | 3 | CID000100806 | |
| Drug | AC1Q6P06 | 6.63e-05 | 25 | 72 | 3 | CID000160263 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 6.63e-05 | 25 | 72 | 3 | CID000043264 | |
| Drug | allocolchicine | 6.63e-05 | 25 | 72 | 3 | CID000196989 | |
| Drug | 1069C85 | 6.63e-05 | 25 | 72 | 3 | CID006918099 | |
| Drug | 55623-37-5 | 6.63e-05 | 25 | 72 | 3 | CID006438440 | |
| Drug | CA1P | 6.63e-05 | 25 | 72 | 3 | CID006918545 | |
| Drug | peloruside A | 6.63e-05 | 25 | 72 | 3 | CID006918506 | |
| Drug | AC1L1HOS | 6.63e-05 | 25 | 72 | 3 | CID000004223 | |
| Drug | NSC142227 | 6.63e-05 | 25 | 72 | 3 | CID000073427 | |
| Drug | MDL 27048 | 6.63e-05 | 25 | 72 | 3 | CID006439188 | |
| Drug | zinc sulfate | 6.80e-05 | 69 | 72 | 4 | CID000024424 | |
| Drug | Coomassie blue | 6.92e-05 | 135 | 72 | 5 | CID000019731 | |
| Drug | NSC527981 | 7.48e-05 | 26 | 72 | 3 | CID000352796 | |
| Drug | NSC332029 | 7.48e-05 | 26 | 72 | 3 | CID000100073 | |
| Drug | indibulin | 7.48e-05 | 26 | 72 | 3 | CID000002929 | |
| Drug | pironetin | 7.48e-05 | 26 | 72 | 3 | CID006438891 | |
| Drug | isaxonine | 7.48e-05 | 26 | 72 | 3 | CID000071169 | |
| Drug | AC1L1J4H | 8.40e-05 | 27 | 72 | 3 | CID000004862 | |
| Drug | NSC292222 | 8.40e-05 | 27 | 72 | 3 | CID000099957 | |
| Drug | dinitroanilines | 8.40e-05 | 27 | 72 | 3 | CID000136400 | |
| Drug | NSC D-669356 | 8.40e-05 | 27 | 72 | 3 | CID000178028 | |
| Drug | NSC 370147 | 9.39e-05 | 28 | 72 | 3 | CID000182762 | |
| Drug | NSC72302 | 9.39e-05 | 28 | 72 | 3 | CID000118078 | |
| Drug | AC1L1BQO | 1.04e-04 | 29 | 72 | 3 | CID000001562 | |
| Drug | Aids106696 | 1.04e-04 | 29 | 72 | 3 | CID006475933 | |
| Drug | ddGDP | 1.04e-04 | 29 | 72 | 3 | CID000134739 | |
| Drug | oxibendazole | 1.04e-04 | 29 | 72 | 3 | CID000004622 | |
| Drug | AC1NBBHE | 1.16e-04 | 30 | 72 | 3 | CID004490620 | |
| Drug | eleutherobin | 1.16e-04 | 30 | 72 | 3 | CID006918335 | |
| Drug | azatoxin | 1.16e-04 | 30 | 72 | 3 | CID000125383 | |
| Drug | NSC617668 | 1.16e-04 | 30 | 72 | 3 | CID000357989 | |
| Drug | citostal | 1.16e-04 | 30 | 72 | 3 | CID000018991 | |
| Drug | thiocolchicine | 1.16e-04 | 30 | 72 | 3 | CID000017648 | |
| Drug | Nexus | 1.21e-04 | 152 | 72 | 5 | CID000098527 | |
| Drug | tropone | 1.28e-04 | 31 | 72 | 3 | CID000010881 | |
| Drug | NSC609395 | 1.28e-04 | 31 | 72 | 3 | CID005488798 | |
| Drug | amiprophosmethyl | 1.28e-04 | 31 | 72 | 3 | CID000100524 | |
| Drug | AC7700 | 1.28e-04 | 31 | 72 | 3 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 1.28e-04 | 31 | 72 | 3 | CID000032851 | |
| Drug | AC1L3V8I | 1.28e-04 | 31 | 72 | 3 | CID000122777 | |
| Drug | NSC332598 | 1.28e-04 | 31 | 72 | 3 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 1.28e-04 | 31 | 72 | 3 | CID000023678 | |
| Drug | AC1L1G95 | 1.41e-04 | 32 | 72 | 3 | CID000003583 | |
| Drug | E2-3,4-Q | 1.41e-04 | 32 | 72 | 3 | CID000067402 | |
| Drug | NSC153858 | 1.41e-04 | 32 | 72 | 3 | CID000547450 | |
| Drug | 2-demethylcolchicine | 1.41e-04 | 32 | 72 | 3 | CID000023757 | |
| Drug | CA4P | 1.55e-04 | 33 | 72 | 3 | CID000370232 | |
| Drug | taltobulin | 1.55e-04 | 33 | 72 | 3 | CID006918637 | |
| Drug | mebendazole | 1.55e-04 | 33 | 72 | 3 | CID000004030 | |
| Drug | triethyllead | 1.69e-04 | 34 | 72 | 3 | CID006328106 | |
| Drug | NSC376450 | 1.69e-04 | 34 | 72 | 3 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 1.69e-04 | 34 | 72 | 3 | CID000161091 | |
| Drug | discodermolide | 1.85e-04 | 35 | 72 | 3 | CID000643668 | |
| Drug | 3-methylthymine | 2.05e-04 | 7 | 72 | 2 | CID000123209 | |
| Disease | microlissencephaly (implicated_via_orthology) | 2.02e-09 | 8 | 70 | 4 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 2.02e-09 | 8 | 70 | 4 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 2.02e-09 | 8 | 70 | 4 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 4.89e-07 | 27 | 70 | 4 | DOID:0050453 (implicated_via_orthology) | |
| Disease | MARDEN-WALKER SYNDROME | 5.55e-06 | 2 | 70 | 2 | C0796033 | |
| Disease | salivary gland cancer (implicated_via_orthology) | 5.55e-06 | 2 | 70 | 2 | DOID:8850 (implicated_via_orthology) | |
| Disease | Machado-Joseph disease (implicated_via_orthology) | 3.32e-05 | 4 | 70 | 2 | DOID:1440 (implicated_via_orthology) | |
| Disease | galectin-7 measurement | 8.27e-05 | 6 | 70 | 2 | EFO_0022034 | |
| Disease | mean platelet volume | STK4 SETD1B POLA1 GCC2 FBXO28 TUBA1C BCORL1 PLCB1 RSPH6A PLCE1 | 1.41e-04 | 1020 | 70 | 10 | EFO_0004584 |
| Disease | Leukemia, Megakaryoblastic, of Down Syndrome | 1.54e-04 | 8 | 70 | 2 | C1860789 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.40e-04 | 139 | 70 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | intracranial aneurysm (is_implicated_in) | 3.61e-04 | 12 | 70 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Connective Tissue Diseases | 4.25e-04 | 13 | 70 | 2 | C0009782 | |
| Disease | MYELODYSPLASTIC SYNDROME | 5.49e-04 | 67 | 70 | 3 | C3463824 | |
| Disease | alkaline phosphatase measurement | 6.45e-04 | 1015 | 70 | 9 | EFO_0004533 | |
| Disease | vital capacity | 6.47e-04 | 1236 | 70 | 10 | EFO_0004312 | |
| Disease | Myeloid Leukemia | 8.28e-04 | 18 | 70 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 8.28e-04 | 18 | 70 | 2 | C0023466 | |
| Disease | Adenoid Cystic Carcinoma | 1.75e-03 | 100 | 70 | 3 | C0010606 | |
| Disease | congestive heart failure (is_implicated_in) | 1.87e-03 | 27 | 70 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | suntan | 1.91e-03 | 103 | 70 | 3 | EFO_0004279 | |
| Disease | coronary artery disease | 2.00e-03 | 1194 | 70 | 9 | EFO_0001645 | |
| Disease | lean body mass | 2.08e-03 | 379 | 70 | 5 | EFO_0004995 | |
| Disease | Bilateral Wilms Tumor | 2.16e-03 | 29 | 70 | 2 | C2930471 | |
| Disease | Hematopoetic Myelodysplasia | 2.16e-03 | 29 | 70 | 2 | C2713368 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 2.31e-03 | 30 | 70 | 2 | C1868672 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSGEAEEDEDTMFTM | 1641 | P13611 | |
| GGDGDDMEIFMEEMR | 61 | Q00994 | |
| GDDPMEEDDFMFELS | 1661 | Q5H9F3 | |
| EGDNGMDSDMEEEAD | 196 | Q9H8G2 | |
| GMTDSEEDLDPMEDF | 31 | Q13323 | |
| LDMDGDGQVDFDEFM | 126 | Q9BXU9 | |
| EMMNDAIDDAMGDEE | 141 | O43633 | |
| MEESMEEEEGGSYEA | 1 | Q86Y37 | |
| MLGTLRAMEGEDVED | 1 | Q8NCD3 | |
| MVDLGEDEDEFENFM | 676 | Q9H2T7 | |
| GDFGMDDREIMREGS | 161 | O60216 | |
| NMDEDGFFEGELMDG | 691 | O95153 | |
| GTETEEEDDGMNDMN | 1006 | Q9H1A4 | |
| MMGGQREAATRDDDD | 491 | Q86YJ7 | |
| GEMDDSREGELMDCD | 1231 | Q8NEZ4 | |
| GGEIMFVEASRMDGE | 666 | Q86WA8 | |
| EDMDEGSDEVGEEEM | 16 | Q96JG8 | |
| DEEERMRMAEGGVTS | 41 | P54252 | |
| EEVFSDMTVGEGEMV | 171 | Q6ICG6 | |
| DNIDMIDGDGDDMER | 56 | Q5H9J7 | |
| IDGDGDDMERFMEEM | 61 | Q5H9J7 | |
| DEEERMRMAEGGVTS | 41 | Q9H3M9 | |
| EEVSDMGNDDPEMGE | 136 | O00566 | |
| GVIISEHGEDEMDME | 176 | Q9Y5B6 | |
| AMEFEDGDFDEPMEV | 246 | P09884 | |
| MGTEEDENFMLDEGF | 246 | Q15646 | |
| GLMEVEFMSGTADED | 1301 | Q92729 | |
| MEDSEMDFDSGLEDD | 21 | Q14686 | |
| ADTEEMDIEMDSGDE | 396 | Q9UBB5 | |
| VGTVGMDMDEDDDFS | 4006 | P04114 | |
| MGGGRDSEEMEIDGD | 116 | Q9UDY4 | |
| GEEEEEAAMYEEEME | 131 | Q14320 | |
| MAAAAEERMAEEGGG | 1 | Q9NVF7 | |
| DMHTVTREEGEGMET | 1506 | Q8IWJ2 | |
| MGFSNMEDDGPEEEE | 601 | Q3T8J9 | |
| EEDEEDPVRGDMFRM | 286 | O94769 | |
| SDEDDRGEMADFGAM | 336 | Q9P0J7 | |
| DDDDDERADDTLFMM | 456 | P22681 | |
| SPDFMIGEEDDDLMD | 1561 | Q15648 | |
| MALEVGDMEDGQLSD | 1 | Q9H814 | |
| GAMSEEDFIEEAEVM | 396 | Q08881 | |
| EMTEGGEVMEAHGEE | 376 | Q9H0K4 | |
| GSEDMKEGGIDMDAF | 291 | P29083 | |
| MRDEDYEGDMEEEVE | 86 | Q8WV44 | |
| DMSNIDLVEGDEGRM | 241 | Q2TB90 | |
| LMRGESGEVTDDEMA | 1091 | Q9P212 | |
| RMSDEGRMVQDEADG | 501 | Q8WV41 | |
| EEEEMVAEESMASAG | 1191 | Q9UPS6 | |
| EGFEGEMDMRPGDED | 256 | Q8WYR4 | |
| LDDMEEMDGLSDFTG | 376 | Q96QV1 | |
| EEMEAEGDSAAEMNG | 11 | Q9HCU9 | |
| APDMGFEMRHEDEDQ | 621 | P17040 | |
| RIEDLNEGMDFDTMD | 1181 | Q8N3U4 | |
| DDEDDEDLMMASGRP | 356 | O75717 | |
| EDDMTESGMAREESD | 2041 | Q9H5I5 | |
| MADEEAGGTERMEIS | 1 | Q8IWV7 | |
| ADGDDEEMMATEVTP | 991 | Q9HAV4 | |
| VAEEDEDDDGGIMMR | 751 | P19634 | |
| EEVEGEEGGMVVEMD | 101 | Q13563 | |
| DEGTAGSEAMATEEM | 526 | Q9NQ66 | |
| EEEMDYGESEEPMGD | 286 | Q9UPT8 | |
| DEMGFSNMEDDGPEE | 76 | Q9H869 | |
| SKEEEMDDMDRDLGD | 256 | Q9HD45 | |
| METVFEEMDEESTGG | 1 | Q5GH77 | |
| EEMEDEEAMAEVGDD | 246 | Q8TF50 | |
| EEDEMDSGTMVRAVG | 321 | Q13043 | |
| EGMEEGEFSEAREDM | 411 | Q71U36 | |
| GMEDGSDDMDTSVED | 2396 | Q70CQ2 | |
| GDHSMDDSSEDGKME | 1186 | O60315 | |
| EGMEEGEFSEAREDM | 411 | P68363 | |
| EGMEEGEFSEAREDM | 411 | Q9BQE3 | |
| EGMEEGEFSEAREDM | 411 | P68366 | |
| REEGMDVEEGEMGDE | 206 | Q96FV9 |